Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA

Zhang, Zhikuan, Ohto, Umeharu, Shibata, Takuma, Krayukhina, Elena, Taoka, Masato, Yamauchi, Yoshio, Tanji, Hiromi, Isobe, Toshiaki, Uchiyama, Susumu, Miyake, Kensuke, Shimizu, Toshiyuki·2016·Immunity

DOI 10.1016/j.immuni.2016.09.011

Cited by (476)

Items 201–300 of 476

Genetic variation analyses indicate conserved SARS‐CoV‐2–host interaction and varied genetic adaptation in immune response factors in modern human evolution
Ji‐Won Lee, In‐Hee Lee, Takanori Sato, Sek Won Kong, Tadahiro Iimura · 2021 · Development Growth & Differentiation
Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8
Xiaoyu Wang, Yu Chen, Steven Zhang, Jinxia Nancy Deng · 2022 · PLoS ONE
The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer Immunotherapy
Daniel H. O’Donovan, Yumeng Mao, Deanna A. Mele · 2019 · Current Medicinal Chemistry
Extracellular vesicles from obese visceral adipose promote pancreatic cancer development and resistance to immune checkpoint blockade therapy
Chunling Xue, Sihan Zhao, Yifan Zhou, Ziming Chen, Ji Liu, Shuang Deng, Lingxing Zeng, Hongzhe Zhao, Zilan Xu, Mei Li et al. · 2025 · Cell Metabolism
Evolution of toll-like receptor gene family in amphibians
Lei Zhang, Guangshuai Liu, Tian Xia, Xiufeng Yang, Guolei Sun, Chao Zhao, Chunzhu Xu, Honghai Zhang · 2022 · International Journal of Biological Macromolecules
Nephropathogenic Infectious Bronchitis Virus Mediates Kidney Injury in Chickens via the TLR7/NF-κB Signaling Axis
Ning Li, Cheng Huang, Wei Chen, Zhengqing Li, Guoliang Hu, Guyue Li, Ping Liu, Ruiming Hu, Zhuang Yu, Junrong Luo et al. · 2022 · Frontiers in Cellular and Infection Microbiology
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists
Sourav Pal, Uddipta Ghosh Dastidar, Trisha Ghosh, Dipyaman Ganguly, Arindam Talukdar · 2022 · Molecules
The role of toll-like receptors (TLRs) in pan-cancer
Runzhi Huang, Zehui Sun, Shuyuan Xian, Dianwen Song, Zhengyan Chang, Penghui Yan, Jie Zhang, Huabin Yin, Zixuan Zheng, Peng Hu et al. · 2022 · Annals of Medicine
The characterization of toll‐like receptor repertoire in Pinna nobilis after mass mortality events suggests adaptive introgression
Stéphane Coupé, Ioannis Α. Giantsis, Maite Vázquez‐Luis, Fabio Scarpa, Mathieu Foulquié, Jean‐Marc Prévot, Marco Casu, Athanasios Lattos, Basile Michaelidis, Daria Sanna et al. · 2023 · Ecology and Evolution
Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9
Muhammad Haseeb, Yang Seon Choi, Mahesh Chandra Patra, Uisuk Jeong, Wang Hee Lee, Naila Qayyum, Hongjoon Choi, Wook Kim, Sangdun Choi · 2024 · Journal of Chemical Information and Modeling
Emerging Concepts in Innate Immunity
Karin Pelka, Dominic De Nardo · 2017 · Methods in molecular biology
Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
Jelka Pohar, Duško Lainšček, Ana Kunšek, Miša Mojca Cajnko, Roman Jerala, Mojca Benčina · 2017 · Scientific Reports
RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy
Hongxia Zhang, Xiaojun Xia · 2021 · Human Vaccines & Immunotherapeutics
Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations
Sourav Pal, Barnali Paul, Purbita Bandopadhyay, Nagothy Preethy, Dipika Sarkar, Oindrila Rahaman, Sunny Goon, Swarnali Roy, Dipyaman Ganguly, Arindam Talukdar · 2020 · European Journal of Medicinal Chemistry
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits
Nirmal Das, Purbita Bandopadhyay, Swarnali Roy, Bishnu Prasad Sinha, Uddipta Ghosh Dastidar, Oindrila Rahaman, Sourav Pal, Dipyaman Ganguly, Arindam Talukdar · 2022 · Journal of Medicinal Chemistry
DSP-0509, a systemically available TLR7 agonist, exhibits combination effect with immune checkpoint blockade by activating anti-tumor immune effects
Yosuke Ota, Yasuhiro Nagai, Yuko Hirose, Seiji Hori, Erina Koga‐Yamakawa, Ken Eguchi, Kentaro Sumida, Masashi Murata, Hiroki Umehara, Setsuko Yamamoto · 2023 · Frontiers in Immunology
Enantioselective Effect of Chiral Small Molecules in SARS‐CoV‐2 Vaccine‐Induced Immune Response
Zhengmiao Zhou, Yufang Zhang, Honghan Ji, Yu Jin, Sisi Chen, Pengfei Duan, Ye Liu · 2023 · Angewandte Chemie International Edition
Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy
Fang Li, Biao Song, Wei-Feng Zhou, Li-Jin Chu · 2023 · Viral Immunology
Structure–Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri T. Patil, Binita Sihag, Sakshi Piplani, Isaac G. Sakala, Yoshikazu Honda‐Okubo, Saravanan Ramakrishnan, Nikolai Petrovsky, Deepak B. Salunke · 2024 · Journal of Medicinal Chemistry
Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice
Ivy L. Debreceni, Michael S. Chimenti, DAVID V. SERREZE, Aron M. Geurts, Yi‐Guang Chen, Scott M. Lieberman · 2020 · International Journal of Molecular Sciences
Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing human blood–brain barrier
Phetcharawan Lye, Enrrico Bloise, Stephen G. Matthews · 2023 · Fluids and Barriers of the CNS
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms
You-Sheng Lin, Yung‐Chi Chang, Tzu-Yu Pu, Tsung‐Hsien Chuang, Li-Chung Hsu · 2025 · Journal of Biomedical Science
Evolution of RNA sensing receptors in birds
Katharine E. Magor · 2022 · Immunogenetics
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity
Arthur Μ. Krieg · 2025 · Journal for ImmunoTherapy of Cancer
RNA-Cholesterol Nanoparticles Function as Potent Immune Activators via TLR7 and TLR8
Hannah-Lena Obermann, Ines Lederbogen, Jenny Steele, Jens Dorna, Leif Erik Sander, Konrad H. Engelhardt, Udo Bakowsky, Andreas Martin Kaufmann, Stefan Bauer · 2022 · Frontiers in Immunology
Extension and refinement of the recognition motif for Toll-like receptor 5 activation by flagellin
Karolina Ivičak‐Kocjan, Vida Forstnerič, Gabriela Panter, Roman Jerala, Mojca Benčina · 2018 · Journal of Leukocyte Biology
Comparative transcriptome analysis of TLR8 signaling cells revealed the porcine TLR8 specific differentially expressed genes
Da Ao, Pengpeng Xia, Sen Jiang, Nanhua Chen, François Meurens, Jianzhong Zhu · 2019 · Developmental & Comparative Immunology
R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice
Spyridon Makris, Cecilia Johansson · 2020 · Mucosal Immunology
Helicobacter pylori Infection Elicits Type I Interferon Response in Human Monocytes via Toll-Like Receptor 8 Signaling
Chalystha Yie Qin Lee, Yee Teng Chan, Yi Ying Cheok, Grace Min Yi Tan, Ting Fang Tang, Heng Choon Cheong, Jamuna Vadivelu, Suhailah Abdullah, Chung Yeng Looi, Won Fen Wong · 2022 · Journal of Immunology Research
Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists
Serge Pieters, David C. McGowan, Florence Herschke, Frederik Pauwels, Bart Stoops, Stefaan Last, Werner Embrechts, Annick Scholliers, Wendy Mostmans, Kris Van Dijck et al. · 2018 · Bioorganic & Medicinal Chemistry Letters
NAT10 and N 4 -acetylcytidine restrain R-loop levels and related inflammatory responses
Turja K. Debnath, Nathan S. Abell, Yi-Ru Li, Sravan K. Devanathan, Enrique Navedo, Blerta Xhemalçe · 2025 · Science Advances
Novel TLR7/8 agonists promote activation of HIV-1 latent reservoirs and human T and NK cells
Yangyang Li, Zhisong Wang, Ying Hou, Xiaoyu Liu, Junxian Hong, Xuanling Shi, Xiaojie Huang, Tong Zhang, Xuebin Liao, Linqi Zhang · 2023 · Frontiers in Microbiology
Immunoactive signatures of circulating tRNA- and rRNA-derived RNAs in chronic obstructive pulmonary disease
Megumi Shigematsu, Takuya Kawamura, Deepak A. Deshpande, Yohei Kirino · 2024 · Molecular Therapy — Nucleic Acids
Structure-aware machine learning identifies microRNAs operating as Toll-like receptor 7/8 ligands
Raden, Martin, Wallach, Thomas, Miladi, Milad, Zhai, Yuanyuan, Krüger, Christina, Mossmann, Zoé J., Dembny, Paul, Backofen, Rolf, Lehnardt, Seija · 2021 · RNA Biology
Adaptation and Cryptic Pseudogenization in Penguin Toll-Like Receptors
Steven R. Fiddaman, Michal Vinkler, Simon Spiro, Hila Levy, Christopher A. Emerling, Amy C. Boyd, Evangelos A. Dimopoulos, Juliana A. Vianna, Theresa L. Cole, Hailin Pan et al. · 2021 · Molecular Biology and Evolution
TLR7 and IgM: Dangerous Partners in Autoimmunity
Timm Amendt, Philipp Yu · 2023 · Antibodies
Conservation and Divergence of Ligand Recognition and Signal Transduction Mechanisms in Toll-Like Receptors
Umeharu Ohto · 2017 · Chemical and Pharmaceutical Bulletin
Endolysosomal compartments as platforms for orchestrating innate immune and metabolic sensors
Kensuke Miyake, Shin-ichiroh Saitoh, Ryota Sato, Takuma Shibata, Ryutaro Fukui, Yusuke Murakami · 2019 · Journal of Leukocyte Biology
Structure-guided approaches to modulate endosomal toll-like receptors TLR7, TLR8 and TLR9: advances, challenges and therapeutic promise
Troy Matziol, Valerij Talagayev, Günther Weindl, Gerhard Wolber · 2025 · Drug Discovery Today
Investigation of binding characteristics of immobilized toll-like receptor 3 with poly(I:C) for potential biosensor application
Kristin Topping, David G. Kelly · 2018 · Analytical Biochemistry
Ash1L ameliorates psoriasis via limiting neuronal activity‐dependent release of miR‐let‐7b
Wan‐Jie Du, Huan Yang, Fang Tong, Shuai Liu, Chen Zhang, Yeying Chen, Yuze Yan, Yan‐Wei Xiang, Lingyang Hua, Ye Gong et al. · 2023 · British Journal of Pharmacology
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody–Drug Conjugate Payloads
Akash M. Patel, Aarron T. Willingham, Alan C. Cheng, Daniela M. Tomazela, Eddie Bowman, Esther Kofman, Fan Zhang, Jianming Bao, Jillian R. Sanzone, Jonathan W Choy et al. · 2024 · Journal of Medicinal Chemistry
Innate immune TLR7 signaling mediates platelet activation and platelet-leukocyte aggregate formation in murine bacterial sepsis
Brittney Williams, Jing Zhu, Lin Zou, Wei Chao · 2022 · Platelets
Generation and structure-activity relationships of novel imidazo-thienopyridine based TLR7 agonists: application as payloads for immunostimulatory antibody drug-conjugates
Michael G. Brant, Graham A. E. Garnett, Joy Guedia, Manuel Lasalle, Samuel O. Lawn, Mark E. Petersen, Renee Duan, José Méndez-Campos, Truman Hirkala-Schaefer, Geoffrey C. Winters et al. · 2023 · Bioorganic & Medicinal Chemistry Letters
Imidazoquinolines with improved pharmacokinetic properties induce a high IFNα to TNFα ratio in vitro and in vivo
Manuel Keppler, Simon Straß, Sophia Geiger, Tina Fischer, Nadja Späth, Thilo Weinstein, Anna Schwamborn, Jamil Guezguez, Jan‐Hinrich Guse, Stefan Laufer et al. · 2023 · Frontiers in Immunology
Immunostimulatory short non-coding RNAs in the circulation of patients with tuberculosis infection
Justin Gumas, Takuya Kawamura, Megumi Shigematsu, Yohei Kirino · 2024 · Molecular Therapy — Nucleic Acids
The Role of RNA Editing in the Immune Response
Sadeem Ahmad, Xin Ni Mu, Sun Hur · 2020 · Methods in molecular biology
Disease in the Pld4thss/thss Model of Murine Lupus Requires TLR9
Amanda Lee Gavin, Tanya R. Blane, Therese C. Thinnes, Emma H. Gerlt, Ann Marshak‐Rothstein, Deli Huang, David A. Nemazee · 2023 · ImmunoHorizons
miR-154-5p Is a Novel Endogenous Ligand for TLR7 Inducing Microglial Activation and Neuronal Injury
McGurran, Hugo, Kumbol, Victor, Krüger, Christina, Wallach, Thomas, Lehnardt, Seija · 2024 · Cells
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I. van der Made, Gayatri Ramakrishnan, Eamon Coughlan, Rosanna Asselta, Britt-Sabina Löscher, Luca V. C. Valenti, Rafael de Cid, Luís Bujanda, Antonio Julià et al. · 2024 · Human Genetics and Genomics Advances
Dynamic control of nucleic-acid-sensing Toll-like receptors by the endosomal compartment
Kensuke Miyake, Shin-ichiroh Saitoh, Ryutaro Fukui, Takuma Shibata, Ryota Sato, Yusuke Murakami · 2021 · International Immunology
TLR8 is activated by 5ʹ-methylthioinosine, a Plasmodium falciparum-derived intermediate of the purine salvage pathway
Gabriele V. Köllisch, Francisco Venegas Solis, Hannah-Lena Obermann, Jeannine Eckert, Thomas R Müller, Tim Vierbuchen, Thomas Rickmeyer, Simon Muche, Jude M. Przyborski, Holger Heine et al. · 2022 · Cell Reports
Invasion by exogenous RNA: cellular defense strategies and implications for RNA inference
Danxu Tang, Yan Liu, Chundi Wang, Lifang Li, Saleh A. Alfarraj, Xiao Chen, Ying Yan · 2023 · Marine Life Science & Technology
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Ryutaro Fukui, Yusuke Murakami, Kensuke Miyake · 2018 · Inflammation and Regeneration
Gene duplication and adaptive evolution of Toll-like receptor genes in birds
Jiandong Yang, Ming Zhou, Yun Zhong, Liqun Xu, Changjun Zeng, Xiaoling Zhao, Ming Zhang · 2021 · Developmental & Comparative Immunology
TREX1 exonuclease in immunity and disease
Zehua Shang, Lei Wang, Wen Zhou · 2025 · International Immunology
Unveiling the potential of natural TLR modulators in cancer immunotherapy
Wenying Zheng, Junming Chen, Jiajun Liu, Xintong Han, Siyuan Zhang, Chao Yang, Hua Yu, Wen Tan, Zhangfeng Zhong · 2025 · Pharmacological Research
Cytidine deaminase enables Toll-like receptor 8 activation by cytidine or its analogs
Katsuhiro Furusho, Takuma Shibata, Ryota Sato, Ryutaro Fukui, Yuji Motoi, Yun Zhang, Shin-ichiroh Saitoh, Takeshi Ichinohe, Masafumi Moriyama, Seiji Nakamura et al. · 2018 · International Immunology
TLR5 binding and activation by KMRC011, a flagellin-derived radiation countermeasure
Wan Seok Song, Jee-Hyeon Kim, Chi‐Min Choi, Woo‐Jong Lee, Sung‐il Yoon · 2018 · Biochemical and Biophysical Research Communications
Adaptive genetic variation at three loci in South African vervet monkeys ( Chlorocebus pygerythrus ) and the role of selection within primates
Willem G. Coetzer, Trudy R. Turner, Christopher A. Schmitt, J. Paul Grobler · 2018 · PeerJ
IFN-Induced PARPs—Sensors of Foreign Nucleic Acids?
Katharina Biaesch, Sarah Knapp, Patricia Korn · 2023 · Pathogens
Characterization of cooperative PS-oligo activation of human TLR9
Adam J. Pollak, Luyi Zhao, Stanley T. Crooke · 2023 · Molecular Therapy — Nucleic Acids
RNase T2 deficiency promotes TLR13-dependent replenishment of tissue-protective Kupffer cells
Ryota Sato, Kaiwen Liu, Takuma Shibata, Katsuaki Hoshino, Kiyoshi Yamaguchi, Toru Miyazaki, Ryosuke Hiranuma, Ryutaro Fukui, Yuji Motoi, Yuri Fukuda‐Ohta et al. · 2024 · The Journal of Experimental Medicine
Comparative analyses for plant virus-based cancer immunotherapy drug development
Anthony O. Omole, Hannah S. Newton, Edward Cedrone, Kimia Nematpour, Shaojun Xie, Yongmei Zhao, Bao Tran, Marina A. Dobrovolskaia, Nicole F. Steinmetz · 2025 · Cell Biomaterials
Toll-like Receptor 7 (TLR7) Is Expressed in Adipocytes and the Pharmacological TLR7 Agonist Imiquimod and Adipocyte-Derived Cell-Free Nucleic Acids (cfDNA) Regulate Adipocyte Function
Miriam Thomalla, Andreas Schmid, Julia Hehner, Sebastian Koehler, Elena Neumann, Ulf Müller‐Ladner, Andréas Schäffler, Thomas Karrasch · 2022 · International Journal of Molecular Sciences
Extracellular RNA Sensing Mediates Inflammation and Organ Injury in a Murine Model of Polytrauma
Andrew Suen, Fengqian Chen, Sheng Wang, Ziyi Li, Jing Zhu, Yang Yang, Olivia Conn, Kerri Lopez, Ping Cui, Laurence Wechsler et al. · 2023 · The Journal of Immunology
Synthesis and Optimization of 1‑Substituted Imidazo[4,5‑ c ]quinoline TLR7 Agonists
Emma G. DeYoung, Justin M. Howe, Siteng Fang, Mullapudi Mohan Reddy, Jillian P. Handel, Jared T. Gillen Miller, Daniel R. Wheeler, L. Nathan Tumey · 2023 · ACS Medicinal Chemistry Letters
Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7
Isabell Hellmuth, Isabel Freund, Janine Schlöder, Salifu Seidu‐Larry, Kathrin L. Thüring, Kaouthar Slama, Jens Langhanki, Stefka S. Kaloyanova, Tatjana Eigenbrod, Matthias Krumb et al. · 2017 · Frontiers in Immunology
Epigenetic Mechanisms in Immune Disease: The Significance of Toll-Like Receptor-Binding Extracellular Vesicle-Encapsulated microRNA
Steffi Bösch, Nicholas A. Young, Grégoire Mignot, Jean‐Marie Bach · 2020 · Frontiers in Genetics
The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity
Justyna Agier, Ewa Brzezińska‐Błaszczyk, Piotr Witczak, Elżbieta Kozłowska, Paulina Żelechowska · 2020 · Cellular Immunology
IRAK1 inhibition blocks the HIV-1 RNA mediated pro-inflammatory cytokine response from microglia
Grant R. Campbell, Pratima Rawat, Carmen Teodorof‐Diedrich, Stephen A. Spector · 2023 · Journal of General Virology
Nucleic acid triggers of autoimmunity and autoinflammation
Kaiyuan Hao, Ann Marshak‐Rothstein · 2025 · Current Opinion in Immunology
Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands
Akihito Baba, Masahiro Wakao, Hiroyuki Shinchi, Michael Chan, Tomoko Hayashi, Shiyin Yao, Howard Brinkerhoff Cottam, Dennis Anthony Carson, Yasuo Suda · 2019 · Bioorganic & Medicinal Chemistry Letters
Toll-like receptor 7: A novel neuroimmune target to reduce excessive alcohol consumption
Ruth L. Allard, Jody Mayfield, Riccardo Barchiesi, Nihal A. Salem, Roy Dayne Mayfield · 2024 · Neurobiology of Stress
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects
Chris T.P. Do, Jack Yancy Prochnau, A. Mediero Domínguez, Pei Wang, Manjeet K. Rao · 2024 · Biomedicines
The evolutionary characteristics and structural biology of Gallus toll‐like receptor 21
Hongping Wu, Hai Wang, Wuqi Jiang, Zhengxing Lian · 2017 · Journal of Molecular Recognition
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
Johannes Falke, Christina A. Hulsbergen‐van de Kaa, Roberto Maj, Egbert Oosterwijk, Johannes Alfred Witjes · 2018 · World Journal of Urology
mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, Shayan Sharif · 2024 · Viruses
miR-574-5p in epigenetic regulation and Toll-like receptor signaling
James Y. Yang · 2024 · Cell Communication and Signaling
Design, Synthesis, and Biological Evaluation of BODIPY-Caged Resiquimod as a Dual-Acting Phototherapeutic
Eslam Roshdy, Haruto Taniguchi, Yoki Nakamura, Haruko Takahashi, Yutaka Kikuchi, İsmail Çeli̇k, Elsayed S. I. Mohammed, Yasuhiro Ishihara, Norimitsu Morioka, Manabu Abe · 2025 · Journal of Medicinal Chemistry
Sequence-specific extracellular microRNAs activate TLR7 and induce cytokine secretion and leukocyte migration
Niming Wu, Brenda Morsey, Katy M. Emanuel, Howard S. Fox · 2021 · Molecular and Cellular Biochemistry
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling
Oscar A Peña, Alexandra Lubin, Jasmine Rowell, Catherine Hockings, Youngrock Jung, Yvette Hoade, Phoebe Dace, Leonardo E. Valdivia, Karin Tuschl, Charlotta Böiers et al. · 2021 · Blood Advances
Evaluation of a Lipopolysaccharide and Resiquimod Combination as an Adjuvant with Inactivated Newcastle Disease Virus Vaccine in Chickens
Bal Krishan Sharma, Saravanan Ramakrishnan, Abinaya Kaliappan, Mithilesh Kumar Singh, Ajay Kumar, Satyabrata Dandapat, Sohini Dey, Madhan Mohan Chellappa · 2022 · Vaccines
Nucleic Acid Nanostructure Assisted Immune Modulation
Xiaoli Sun, Haipeng Liu · 2020 · ACS Applied Bio Materials
Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics
Ardavan Abiri, Masoud Rezaei, Mohammad Hossein Zeighami, Younes Vaezpour, Leili Dehghan, Maedeh KhorramGhahfarokhi · 2021 · Informatics in Medicine Unlocked
How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
Mouldy Sioud · 2023 · Scandinavian Journal of Immunology
Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus
Meng Wang, Hekai Chen, Tuan Zhang, Zhikuan Zhang, Xuwen Xiang, Meng Gao, Yilan Guo, Shuangshuang Jiang, Kejun Yin, Mintao Chen et al. · 2024 · Acta Pharmaceutica Sinica B
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity
Valentina Salvi, Carolina Gaudenzi, Barbara Mariotti, Gaia Giongrandi, Silvia Alacqua, Veronica Gianello, Tiziana Schioppa, Laura Tiberio, Angela Ceribelli, Carlo Francesco Selmi et al. · 2024 · Cell Communication and Signaling
Catch me if you can: viral nucleic acids to host sensors
Yohan Jung, Harmony Grainger, Shizhuo Yang, Sohaumn Mondal, Kiven Erique Lukong, Kristen L. Conn, Yuliang Wu · 2025 · Frontiers in Immunology
Anti-human TLR7 antibody for therapeutic intervention in systemic lupus erythematosus
Ryutaro Fukui, Yusuke Murakami, Atsuo Kanno, Yuji Motoi, Atsushi Manno, Tomohiro Honda, Shinnosuke Yamada, Jun Ishiguro, Takashi Kagari, Kensuke Nakamura et al. · 2025 · International Immunology
Self-referential immune recognition through C-type lectin receptors
Carla Guenther, Masamichi Nagae, Sho Yamasaki · 2022 · Advances in immunology
Expression of Toll-like Receptor Genes and Antiviral Cytokines in Macrophage-like Cells in Response to Indole-3-carboxylic Acid Derivative
Alexander N. Narovlyansky, Alexander V. Pronin, Полосков Владислав Васильевич, Sanin Av, Marina V. Mezentseva, Федякина Ирина Тимофеевна, И. А. Суетина, Zubashev Ik, Ershov Fi, М. В. Филимонова et al. · 2024 · Viruses
Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists
Troy Matziol, Valerij Talagayev, Tjaša Slokan, Nika Strašek Benedik, Janine Holze, Matej Sova, Gerhard Wolber, Günther Weindl · 2025 · Journal of Medicinal Chemistry
Nucleoside analogs in the study of the epitranscriptome
Cody M. Palumbo, Peter A. Beal · 2018 · Methods
Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells
John Victor Napoleon, Boning Zhang, Qian Luo, Madduri Srinivasarao, Philip Stewart Low · 2022 · Angewandte Chemie International Edition
Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology
Yam B. Poudel, Liqi He, Matthew Cox, Qian Zhang, Walter L. Johnson, Qiang Cong, Heng Wei Cheng, Naidu S. Chowdari, Christine M. Tarby, Andrew F. Donnell et al. · 2024 · ACS Medicinal Chemistry Letters
Genetic variation among different springbok (Antidorcas marsupialis) colour variants
Willem G. Coetzer, J. Paul Grobler · 2019 · Mammalian Biology
Nucleosides drive histiocytosis in SLC29A3 disorders by activating TLR7
Takuma Shibata, Masato Taoka, Shin-ichiroh Saitoh, Yoshio Yamauchi, Yuji Motoi, Mayumi Komine, Etsuko Fujita, Ryota Sato, Hiroshi Sagara, Takeshi Ichinohe et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity
Arnau Antolí, Gardenia Vargas‐Parra, Àngels Sierra-Fortuny, Jose Luis Gomez-Vazquez, Paula Rofes, Elisabet Munté, Julen Viana-Errasti, Raúl Marín-Montes, Adriana López‐Doriga, Lídia Feliubadaló et al. · 2025 · Journal of Clinical Immunology
Immunological mechanisms of mRNA vaccines for infectious diseases
Michela Locci, Norbert Pardi · 2026 · Nature